Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
about
Eradication therapy for peptic ulcer disease inHelicobacter pylori-positive peopleEradication therapy for peptic ulcer disease in Helicobacter pylori positive patientsNew concepts of resistance in the treatment of Helicobacter pylori infectionsHelicobacter pyloriEfficacy of Helicobacter pylori eradication therapies: a single centre observational studyAntibiotic treatment for Helicobacter pylori: Is the end coming?Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsDiagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infectionsA prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinicA multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China.One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.Treatment of H. pylori infection: the reality.Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phaseComparison of five-day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based regimens with and without omeprazole pretreatmentOmeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian populationEradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.Antimicrobial susceptibilities of Helicobacter pylori isolates under microaerophilic atmospheres established by two different methods.Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay.Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 studyReview article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.Efficacy of one-day quadruple therapy for H pylori infection in Chinese patientsProton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.Structural basis for shikimate-binding specificity of Helicobacter pylori shikimate kinase.Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsiaImproving compliance with helicobacter pylori eradication therapy: when and how?Treating Helicobacter pylori--the best is yet to come?Treatment of Helicobacter pylori infection: Past, present and futureTreatment of Helicobacter pylori.Tinidazole: from protozoa to Helicobacter pylori--the past, present and future of a nitroimidazole with peculiarities.Update on the management of Helicobacter pylori infection, including drug-resistant organisms.Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.Antibiotic resistance of Helicobacter pylori strains in Japanese childrenEfficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse modelMacrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patientsDiagnostic methods for Helicobacter pylori detection and eradication
P2860
Q24185883-2D23D124-3E0E-4C60-B87A-8893462261B2Q24246267-68A20293-5131-4713-8155-06C42353074FQ24622513-3CBE26C2-CBD0-4EA4-9704-3CA64F10BFAEQ24683623-526C7D3C-C41A-43D4-BB1E-64BF50027770Q24803928-DC3F40D4-571F-41E4-96B2-1A4D9D34C7D9Q26777623-69118CBA-0F84-4EDA-AD01-6CE1F4FDDED9Q26778023-D364DF9B-E4D6-47C4-95B2-1807E5C16D43Q27027870-7DAFC725-63D2-446A-A3A7-84CA6DDC2BD4Q30481977-4EEB7AB4-FB40-4565-9851-AF06D32F4659Q31795206-79BC97A1-CF4D-403F-BF81-01F6FDE9CDC2Q32026717-0BE471C1-62FF-47C3-8C74-180352DDC923Q32026771-CCAC9D3D-8520-4C38-AFAC-2D145E13ED40Q33667015-05C88881-A662-409C-9F27-18683BBA2F50Q33687984-6A5DF4D4-8340-47B5-8E47-6F5E074BC9DCQ33739015-DCFC28D3-B686-48F9-A1A3-5CD34F3FDB83Q33787766-87CC430D-129E-4142-8940-E7D26DDB22C0Q33889788-35985206-C785-4429-AB65-BDE16B88A576Q33904326-B4B81661-2F17-4E33-A58A-1BB75DEBCB3AQ33972965-8761CD6E-4BED-422C-86A0-0760E15D3EECQ33974794-A0B165A8-51F2-4FA4-870C-5F86ED138894Q33978090-B9C0D04A-63DF-41D7-9E45-443F1EA1B6CFQ33994162-45EF2373-9358-45D7-8966-58F221F2A8DFQ34012991-47D6C6C3-9ED7-42DC-A091-FE1E1A3FFEC3Q34049805-2523F02C-AB88-44E6-B84D-C0E68ABD9424Q34150938-F6DA0DF8-9AA9-456C-8CF8-63018E2D3617Q34291666-1F0B9018-9F1A-44EE-B26E-42806C5F89F9Q34312326-D4F74410-821A-4A7C-A5A4-01C8FA55FF8CQ34409052-8054953F-69BA-44E0-B1FC-0C567A7860D1Q34410607-01768009-4F15-419F-8EF9-A680E36CF8C6Q34508830-2B12FBC3-7237-45AF-B7AB-A9740759A4E2Q34512048-8DF2524C-8C9F-4603-A7C4-8658E9E4F5D6Q34551841-48CA3D68-2E87-4B52-B7AF-A950A0E6B8DEQ34619427-507E7D4C-6646-4C5A-B481-CD810C543999Q34827671-11692B21-DC32-4540-9235-5240F0FB01E5Q34946883-158A70EC-9596-4569-AC82-69C05E285B24Q35010214-F460884D-AFAD-4769-B1B0-E10CE906E29EQ35011405-2F57B966-6CB1-4ADF-916C-360118F79BF2Q35102815-B9C4F2C1-6573-4696-A7F2-D613774A04BEQ35139076-DE8192D2-8958-4452-B754-E1FF1A98A043Q35200053-33108DAA-8A9D-4FC6-8CD4-841948A2D3AE
P2860
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Eradication of Helicobacter py ...... imicrobials: the MACH I Study.
@en
Eradication of Helicobacter py ...... imicrobials: the MACH I Study.
@nl
type
label
Eradication of Helicobacter py ...... imicrobials: the MACH I Study.
@en
Eradication of Helicobacter py ...... imicrobials: the MACH I Study.
@nl
prefLabel
Eradication of Helicobacter py ...... imicrobials: the MACH I Study.
@en
Eradication of Helicobacter py ...... imicrobials: the MACH I Study.
@nl
P2093
P1433
P1476
Eradication of Helicobacter py ...... imicrobials: the MACH I Study.
@en
P2093
Bardhan KD
Bayerdörffer E
Bradette M
Cederberg C
Idström JP
O'Morain C
Veldhuyzen van Zanten S
P304
P356
10.1111/J.1523-5378.1996.TB00027.X
P577
1996-09-01T00:00:00Z